This exciting book brings together a high-calibre group of experts to discuss the practical application of genomic information to the development of drugs. The subjects covered include the current state of the art in sequencing technology, the applications of these new technologies to sequencing the genomes of various organisms, and the challenge of proteomics. Additional contributions deal with legal and ethical implications of the new uses of genetic data, and functional genomes from the point of view of the pharmaceutical industry.
Or split into 4x interest-free payments of 25% on orders over R50
Learn more
This exciting book brings together a high-calibre group of experts to discuss the practical application of genomic information to the development of drugs. The subjects covered include the current state of the art in sequencing technology, the applications of these new technologies to sequencing the genomes of various organisms, and the challenge of proteomics. Additional contributions deal with legal and ethical implications of the new uses of genetic data, and functional genomes from the point of view of the pharmaceutical industry.
Imprint | John Wiley & Sons |
Country of origin | United States |
Release date | September 2000 |
Availability | Expected to ship within 12 - 17 working days |
First published | November 2000 |
Authors | Novartis |
Dimensions | 233 x 165 x 18mm (L x W x T) |
Format | Hardcover |
Pages | 174 |
ISBN-13 | 978-0-471-62744-9 |
Barcode | 9780471627449 |
Categories | |
LSN | 0-471-62744-5 |